Effect of intraperitoneal antimicrobials on the concentration of bacteria, endotoxin, and tumor necrosis factor in abdominal fluid and plasma in rats.
The efficacy of intraperitoneal instillation of antimicrobial agents in eliminating the bacterial contaminant in patients with generalized peritonitis remains controversial. We determined the effect of intraperitoneal instillation of taurolidine or imipenem on mortality, and on the concentration of bacteria, endotoxin, and tumor necrosis factor (TNF) in rats with intraperitoneally injected bacteria. Thirty rats were inoculated intraperitoneally with two enteric bacterial strains, followed by either taurolidine, saline, or imipenem. Abdominal fluid and blood were analyzed at different time intervals. The survival rate was highest in the imipenem group (p < 0.05). The bacterial concentration in abdominal fluid in the taurolidine and imipenem group was lower than in the saline group (p < 0.005), but the concentration in the imipenem group was lowest (p < 0.005). The endotoxin concentration in abdominal fluid and plasma in the taurolidine group was lower than in the other two groups (p < 0.05). The TNF concentration in abdominal fluid and plasma in the taurolidine group was lower than in the saline group (p < 0.05), whereas the concentration in the imipenem group was higher (p < 0.005). We conclude that topically applied taurolidine in rats with intraperitoneally injected bacteria may have a weak antibacterial effect, and lowered concentrations of endotoxin and TNF. Topically applied imipenem had a profound bactericidal activity but induced endotoxin and TNF release.
Rosman
C
C
Department of Surgery, University Hospital, Groningen, The Netherlands.
Westerveld
G J
GJ
van Oeveren
W
W
Kooi
K
K
Bleichrodt
R P
RP
D000005:Abdomen; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016470:Bacteremia / Q000378:metabolism* / Q000382:microbiology*; D001419:Bacteria / Q000302:isolation & purification; D001826:Body Fluids / Q000378:metabolism* / Q000382:microbiology*; D015377:Cilastatin / Q000494:pharmacology; D015169:Colony Count, Microbial; D004731:Endotoxins / Q000097:blood / Q000378:metabolism*; D015378:Imipenem / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D008297:Male; D009994:Osmolar Concentration; D051381:Rats; D017208:Rats, Wistar; D016019:Survival Analysis; D013654:Taurine / Q000031:analogs & derivatives / Q000494:pharmacology; D013829:Thiadiazines / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D004731:Endotoxins; D013829:Thiadiazines; D014409:Tumor Necrosis Factor-alpha; D015377:Cilastatin; D013654:Taurine; D015378:Imipenem; C012566:taurolidine